Additional biomarkers for pathological complete response in triple negative breast cancer

被引：1
|
作者：
Weem, Khui Wei [1 ]
Tong, Kah Cheong [2 ]
机构：
[1] Manchester Royal Infirm Hosp, Oxford Rd, Manchester M13 9WL, England
[2] Stepping Hill Hosp, Acute Med Unit, Stockport, England
来源：
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | 2024年 / 16卷
关键词：
biomarkers; BRCA-related cancers; chemotherapy; immunotherapy; PD-L1; inhibitors; targeted therapy; triple-negative breast cancer;
D O I：
10.1177/17588359241267148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Additional biomarkers for pathological complete response in triple negative breast cancer (vol 16, 17588359241267148, 2024)
    Wee, K. W.
    Tong, K. C.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [2] Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancer
    Han, Yiqun
    Wang, Jiayu
    Xu, Binghe
    JOURNAL OF CANCER, 2021, 12 (03): : 936 - 945
  • [3] Tissutal immune profile and pathological complete response in triple negative breast cancer
    Botticelli, Andrea
    Cerbelli, Bruna
    Scagnoli, Simone
    Amabile, Maria Ida
    De Luca, Alessandro
    Fortunato, Lucio
    Costarelli, Leopoldo
    Nuti, Marianna
    D'Amati, Giulia
    Marchetti, Paolo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [4] Predictive biomarkers for pathological complete response in early-stage triple negative breast cancer following neoadjuvant chemotherapy
    Polho, Gabriel Berlingieri
    Testa, Laura
    Barroso-Sousa, Romualdo
    Bonadio, Renata Colombo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience
    Elina Sivina
    Lubova Blumberga
    Gunta Purkalne
    Arvids Irmejs
    Hereditary Cancer in Clinical Practice, 21
  • [6] Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Nakashoji, Ayako
    Matsui, Akira
    Nagayama, Aiko
    Iwata, Yuko
    Sasahara, Manami
    Murata, Yuya
    ONCOLOGY LETTERS, 2017, 14 (04) : 4135 - 4141
  • [7] Predictive markers of complete pathological response to neoadjuvant chemoimmunotherapy in triple negative breast cancer.
    Cankar, Kaja
    Auprih, Masa
    Ovcaricek, Tanja
    Kovac, Anja
    Sarvari, Natasa Snoj
    Dobovisek, Luka
    Borstnar, Simona
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer - single hospital experience
    Sivina, Elina
    Blumberga, Lubova
    Purkalne, Gunta
    Irmejs, Arvids
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2023, 21 (01)
  • [9] A preliminary study on predicting pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Chen, Xi
    Zhou, Zhiguo
    CANCER RESEARCH, 2024, 84 (03)
  • [10] Pathological complete response is associated with excellent outcomes in BRCA mutation associated triple negative breast cancer
    Prochaska, L. H.
    Godwin, A. K.
    Kimler, B. F.
    Lehn, C.
    Klemp, J. R.
    O'Dea, A.
    Elia, M.
    Hoffmann, M. S.
    Crane, G.
    McKittrick, R.
    Sheehan, M.
    Graff, S. L.
    Madhusudhana, S.
    Khan, Q. J.
    Jensen, R. A.
    Sharma, P.
    CANCER RESEARCH, 2017, 77
12345